First-ever brain cancer treatment approved (which stocks benefit?)

7 opportunities algorithms are targeting today

Jazz Pharmaceuticals just got FDA approval for the FIRST treatment for H3 K27M-mutant brain tumors – previously untreatable.

While this breakthrough grabs headlines, institutional algorithms are positioning in 6 OTHER opportunities most investors are missing. Access full story here.

-Christopher

P.S. Energy stocks look terrible... so why is Bank of America upgrading the sector? You really need to read this before it's too late.